JP2020525502A5 - - Google Patents

Download PDF

Info

Publication number
JP2020525502A5
JP2020525502A5 JP2019572458A JP2019572458A JP2020525502A5 JP 2020525502 A5 JP2020525502 A5 JP 2020525502A5 JP 2019572458 A JP2019572458 A JP 2019572458A JP 2019572458 A JP2019572458 A JP 2019572458A JP 2020525502 A5 JP2020525502 A5 JP 2020525502A5
Authority
JP
Japan
Prior art keywords
solvate
hydrate
group
conjugate
chemical formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019572458A
Other languages
English (en)
Japanese (ja)
Other versions
JP7191869B2 (ja
JP2020525502A (ja
Filing date
Publication date
Priority claimed from US15/641,251 external-priority patent/US20190125884A1/en
Priority claimed from US15/691,821 external-priority patent/US10195286B2/en
Application filed filed Critical
Publication of JP2020525502A publication Critical patent/JP2020525502A/ja
Publication of JP2020525502A5 publication Critical patent/JP2020525502A5/ja
Application granted granted Critical
Publication of JP7191869B2 publication Critical patent/JP7191869B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019572458A 2017-07-04 2018-07-02 分子を経膜送達するための化合物及び方法 Active JP7191869B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US15/641,251 2017-07-04
US15/641,251 US20190125884A1 (en) 2017-07-04 2017-07-04 Compounds and methods for trans-membrane delivery of molecules
US201715662665A 2017-07-28 2017-07-28
US15/662,665 2017-07-28
US201715679192A 2017-08-17 2017-08-17
US15/679,192 2017-08-17
US15/691,821 US10195286B2 (en) 2017-07-04 2017-08-31 Compounds and methods for trans-membrane delivery of molecules
US15/691,821 2017-08-31
PCT/IL2018/050714 WO2019008574A1 (en) 2017-07-04 2018-07-02 COMPOUNDS AND METHODS FOR TRANSMEMBRANE ADMINISTRATION OF MOLECULES

Publications (3)

Publication Number Publication Date
JP2020525502A JP2020525502A (ja) 2020-08-27
JP2020525502A5 true JP2020525502A5 (enExample) 2021-08-12
JP7191869B2 JP7191869B2 (ja) 2022-12-19

Family

ID=64903980

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019572458A Active JP7191869B2 (ja) 2017-07-04 2018-07-02 分子を経膜送達するための化合物及び方法

Country Status (8)

Country Link
US (1) US10195286B2 (enExample)
EP (1) EP3648773A4 (enExample)
JP (1) JP7191869B2 (enExample)
CN (1) CN111246855A (enExample)
AU (1) AU2018295899B2 (enExample)
CA (1) CA3068165A1 (enExample)
IL (1) IL271788B1 (enExample)
WO (1) WO2019008574A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018205898B2 (en) 2017-01-09 2020-12-10 Aposense Ltd. Compounds and methods for trans-membrane delivery of molecules
EP3674407A4 (en) * 2017-08-22 2022-01-12 National University Corporation Nagoya University MODIFIED POLYNUCLEOTIDE
JP7820060B2 (ja) * 2018-01-01 2026-02-25 アポセンス リミテッド 分子の膜貫通送達のための化合物および方法
WO2020044349A1 (en) * 2018-08-30 2020-03-05 Aposense Ltd. Compounds, cojugates and compositions for use in the methods for trans-membrane delivery of molecules
JP2024518998A (ja) * 2021-05-13 2024-05-08 プロメガ コーポレイション Ｄｎａ合成の生物発光による検出
WO2023022055A1 (ja) * 2021-08-17 2023-02-23 国立大学法人東海国立大学機構 修飾ポリヌクレオチド

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1622572B1 (en) 2003-04-30 2017-12-20 Sirna Therapeutics, Inc. Conjugates and compositions for cellular delivery
CA2910760C (en) 2007-12-04 2019-07-09 Muthiah Manoharan Targeting lipids
US20120035362A1 (en) 2010-08-03 2012-02-09 Berry And Associates, Inc. Phosphoramidite derivatives of folic acid
JP6669719B2 (ja) * 2014-03-28 2020-03-18 アポセンス リミテッドＡｐｏｓｅｎｓｅ Ｌｔｄ． 分子の膜貫通送達のための化合物および方法
US9993563B2 (en) 2014-03-28 2018-06-12 Aposense Ltd. Compounds and methods for trans-membrane delivery of molecules
AU2018205898B2 (en) * 2017-01-09 2020-12-10 Aposense Ltd. Compounds and methods for trans-membrane delivery of molecules

Similar Documents

Publication Publication Date Title
JP2020525502A5 (enExample)
AU2021203840B2 (en) N4-hydroxycytidine and derivatives and anti-viral uses related thereto
AU710074B2 (en) Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement
JP2020022483A5 (enExample)
JP2020514299A5 (enExample)
US20220370635A1 (en) Compositions containing nucleic acid nanoparticles with modular functionality
RU2006109491A (ru) Новые трициклические нуклеозиды или нуклеотиды в качестве терапевтических средств
AU2017326372B2 (en) Modified oligonucleotides and methods of use
JP2020512843A5 (enExample)
WO2003062256A1 (en) 2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
JP2018530560A5 (enExample)
HRP20191471T1 (hr) Molekule nukleinske kiseline modificirane saharidom
KR950032265A (ko) 폴리아미드-올리고뉴클레오타이드 유도체, 이의 제조방법 및 용도
JP2018525015A5 (enExample)
WO2014169216A2 (en) TEMPLATE-DIRECTED γPNA SYNTHESIS AND γPNA TARGETING COMPOUNDS
AR127325A1 (es) Métodos y composiciones para el tratamiento de la enfermedad renal poliquística
JP2013537404A5 (enExample)
JP2017512774A5 (enExample)
JP2020525502A (ja) 分子を経膜送達するための化合物及び方法
US10385090B2 (en) Nucleotide derivative or salt thereof, nucleotide-derived 5′-phosphate ester or salt thereof, nucleotide-derived 3′-phosphoramidite compound or salt thereof, and polynucleotide
US20240384269A1 (en) Compositions containing nucleic acid nanoparticles and processes related to alteration of their physiochemical characteristics
JP2018518167A5 (enExample)
CN102516339A (zh) 嘧啶并嘧啶化合物及其核苷类似衍生物和制备方法及用途
ES2201805T3 (es) Nuevos gliceril-nucleotidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
KR20190123351A (ko) 개질된 올리고뉴클레오티드 및 이의 치료 용도